Shaw K Aaron, Shiver A Luke, Oakes Tannur, Fletcher Nicholas D
Dwight D. Eisenhower Army Medical Center, Fort Gordon, Georgia.
Medical College of Georgia at Augusta University, Augusta, Georgia.
JBJS Rev. 2022 Feb 7;10(2):01874474-202202000-00005. doi: e21.00188.
»: Slipped capital femoral epiphysis (SCFE) has a well-documented association with underlying endocrine conditions, including thyroid hormone aberrations and parathyroid dysfunction.
»: Recombinant growth hormone therapy has also been identified as a risk factor for the development of SCFE.
»: Presentation before their 10th birthday or after their 16th birthday along with height of <10th percentile are reliable risk factors for identifying children with an SCFE who are at a heightened risk for an underlying endocrinopathy and can been used to guide selective laboratory testing.
»: Patients with unilateral SCFE presentations with an underlying endocrinopathy are at a heightened risk for contralateral slip development and should be treated with prophylactic fixation.
»:股骨头骨骺滑脱(SCFE)与潜在的内分泌疾病有充分记录的关联,包括甲状腺激素异常和甲状旁腺功能障碍。
»:重组生长激素治疗也已被确定为SCFE发生的一个危险因素。
»:在10岁生日前或16岁生日后出现,且身高低于第10百分位数,是识别患有SCFE且有潜在内分泌病高风险儿童的可靠危险因素,可用于指导选择性实验室检查。
»:患有单侧SCFE且有潜在内分泌病的患者对侧发生滑脱的风险增加,应进行预防性固定治疗。